Screenshot(s) from Annual Report of 29 Aug 24, page-16

Oh the delicious hypocrisy in that statement JB. And even on cue it is you that then goes "windbagging" on as usual, all ultimately because you don't even have the basic common knowledge of a common accounting caveat emptor included by auditors in accounting reports you will read of any young, pre-positive cash flow company should it be on an ASX, NYSE, NASDAQ, LSE, FSE, etc listed stock. A little thing called nternational accounting standards might give you some clues. Kind of important to understand if you are making your own investment decisions, let alone starting whole new threads to tell people what to be fearful of in theirs.

Stick to diatribes on the finer details of MOA's in stem cells JB. You are at least well informed there, if condescending. On standard auditing and accounting practices you are just showing your ignorance (and set up a whole new thread to show it):

https://viewpoint.pwc.com/dt/us/en/pwc/accounting_guides/financial_statement_/financial_statement___18_US/chapter_24_risks_and_US/245_going_concern_US.html
https://www.accaglobal.com/uk/en/student/exam-support-resources/professional-exams-study-resources/p7/technical-articles/going-concern.html
https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/deep-dive-going-concern-warnings-8211-no-longer-just-for-auditors-59431004

Yes JB, all the pre-positive cash flow bio-techs globally (and many more non bio-techs) and their annual reports be oversaw by the ASIC, SEC or otherwise, IF they are youthful companies that have never reported a sustained profit, will likely have that caveat in their formally audited reports, particularly if their previous cash flows (Killian et al have explained to you enough times they do not translate necessarily to forward cash flows for CYP) and current liquidity (that would be under a year JB) suggest need of address - which the majority of CYP investors hoping/betting done so by commercial partnership (and indeed MSB's as you insist on referencing), in case you were unaware.

You might have heard of some rich fella called Musk. The rather large company that made him the richest man in the world, before it ever reported a sustained profit, resoundingly featured the caveat in its quarterly and annual reporting with regularity. You are just ill informed on this one JB. Perhaps open a few SEC 10K's and then go quietly into the night now and stop lashing out at people.